2022 年初，宾夕法尼亚大学的研究人员在 Science 期刊发表了一篇重磅研究论文【1】，开发了一种在体内原位生成 CAR-T 细胞的新技术（in vivo CAR-T），通过注射脂质纳米颗粒（LNP）递送 mRNA，在体内重编程 T ...

With immunotherapy increasingly making it out of the lab and into hospitals as a viable way to treat serious conditions like ...

In vivo CAR T cell generation is a pioneering immunotherapy approach that reprograms the immune system to fight cancer and ...

AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...

The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Optiscan has initiated its first in-human breast cancer study at the Royal Melbourne Hospital, marking the start of patient ...

A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct ...